Volpara and image analysis developer ScreenPoint Medical have signed an MOU which will see the two companies seek to bring ScreenPoint’s artificial intelligence–based Transpara detection and decision support software to...
The US Food and Drug Administration (FDA) is moving to improve the quality of mammography and provide more health information to patients, especially in the area of breast density, which...
Volpara’s Board meets in person at RSNA to do a complete strategic review of the company, with a view to the FY2020 budget and beyond.
The second positioning challenge for the CC view is excessive exaggeration of the nipple.
At the top of our list of positioning challenges for the CC view is length of the posterior nipple line (PNL).
Last in our series of MLO view positioning issues is achieving sufficient pectoralis muscle length. An Adequate Pec to Posterior Nipple Line (PNL) metric is achieved when the pectoral muscle...
Second on our “top hits” list of positioning challenges for the MLO view is visibility of the inframammary fold (IMF).
Volpara Solutions has analyzed over 1 million mammograms to identify the top positioning issues affecting mammographic quality.
Breast imaging managers naturally seek the high-quality images that aid in the early detection of breast cancer.
Mayfair Diagnostics in Calgary, Canada, decided to implement VolparaEnterprise software to drive a quality improvement program using breast imaging analytics.